 |
|
|
| |
Italian real life experience of resistance guided
retreatment in HCV infected patients who previously
failed a NS5A inhibitor containing regimen
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
AASLD: The global prevalence of resistance-associated substitutions (RAS) in "unusual" HCV subtypes - (11/25/19)
AASLD: HCV Resistance Patterns in a Worldwide Network of Cohorts of GT-3a infected patients - (11/18/19)
V.C. Di Maio, M. Aragri, C. Masetti, S. Paolucci, B. Bruzzone, E. Degasperi, S. Barbaliscia, T. Pollicino, C. Minichini, V. Calvaruso,
M. Rendina, V. Cento, E. Teti, V. Micheli, V. Ghisetti, E. Polilli, V. Pace Palitti, S. Landonio, I. Lenci, S. Francioso, L. Donnarumma,
L.A. Nicolini, A. Bertoli, M. Starace, C. Pasquazzi, A.P. Callegaro, F. Morisco, G. Cenderello, S. Marenco, R. Gulminetti, S. Novati,
A. Scuteri, P. Andreone, S. Galli, A. Ciancio, V. Sangiovanni, N. Cuomo, A. Raddi, G. Morsica, H. Hasson, V. Borghi, I. Maida,
M. Brunetto, P. Colombatto, R. Cozzolongo, A. De Santis, M. Lichtner, S. Babudieri, E. Biliotti, G. Taliani, T. Santantonio, M. Di
Stefano, C. Paternoster, R. Ganga, M. Puoti, G. Rizzardini, A. Pellicelli, E. Milano, C. Mastroianni, A. Licata, F. Di Lorenzo, A.
Giorgini, L. Sighinolfi, C. Dentone, A. Lleo, B. Rossetti, I. Beretta, P. Lampertico, G. Parruti, N. Coppola, G. Raimondo, M. Zazzi,
M. Andreoni, M. Angelico, C.F. Perno, A. Craxì, F. Ceccherini-Silberstein#
#on behalf of HCV Virology Italian Resistance Network (Vironet C)
|
| |
|
|
|
|
|
